...
首页> 外文期刊>Journal of Medical Physics/Association of Medical Physicists of India >Estimation of the effects of normal tissue sparing using equivalent uniform dose-based optimization
【24h】

Estimation of the effects of normal tissue sparing using equivalent uniform dose-based optimization

机译:使用等效的基于均匀剂量的优化方法估算正常组织备用的效果

获取原文
           

摘要

In this study, we intend to estimate the effects of normal tissue sparing between intensity modulated radiotherapy (IMRT) treatment plans generated with and without a dose volume (DV)-based physical cost function using equivalent uniform dose (EUD). Twenty prostate cancer patients were retrospectively selected for this study. For each patient, two IMRT plans were generated (i) EUD-based optimization with a DV-based physical cost function to control inhomogeneity (EUDWith DV) and (ii) EUD-based optimization without a DV-based physical cost function to allow inhomogeneity (EUDWithout DV). The generated plans were prescribed a dose of 72 Gy in 36 fractions to planning target volume (PTV). Mean dose, D30%, and D5% were evaluated for all organ at risk (OAR). Normal tissue complication probability was also calculated for all OARs using BioSuite software. The average volume of PTV for all patients was 103.02 ± 27 cm3. The PTV mean dose for EUDWith DV plans was 73.67 ± 1.7 Gy, whereas for EUDWithout DV plans was 80.42 ± 2.7 Gy. It was found that PTV volume receiving dose more than 115% of prescription dose was negligible in EUDWith DV plans, whereas it was 28% in EUDWithout DV plans. In almost all dosimetric parameters evaluated, dose to OARs in EUDWith DV plans was higher than in EUDWithout DV plans. Allowing inhomogeneous dose (EUDWithout DV) inside the target would achieve better normal tissue sparing compared to homogenous dose distribution (EUDWith DV). Hence, this inhomogeneous dose could be intentionally dumped on the high-risk volume to achieve high local control. Therefore, it was concluded that EUD optimized plans offer added advantage of less OAR dose as well as selectively boosting dose to gross tumor volume.
机译:在这项研究中,我们打算估计在使用等效均匀剂量(EUD)和不使用基于剂量体积(DV)的物理成本函数的情况下生成的强度调制放射治疗(IMRT)治疗计划之间的正常组织备用的影响。回顾性地选择了20名前列腺癌患者用于该研究。为每位患者生成了两个IMRT计划(i)基于EUD的优化和基于DV的物理成本函数来控制不均匀性(EUD With DV )和(ii)基于EUD的优化而没有DV基于物理的成本函数,以实现不均匀性(EUD 无DV )。按照计划的目标体积(PTV),将生成的计划按36份剂量指定72 Gy剂量。评估所有危险器官(OAR)的平均剂量D 30%和D 5%。还使用BioSuite软件计算了所有OAR的正常组织并发症概率。所有患者的PTV平均体积为103.02±27 cm 3 。具有DV 计划的EUD 的PTV平均剂量为73.67±1.7 Gy,而没有DV 计划的EUD PTV的平均剂量为80.42±2.7 Gy。研究发现,PTV接受剂量超过处方剂量的115%在EUD DV 计划中可以忽略不计,而在EUD DV 计划中则是28%。在评估的几乎所有剂量参数中,带有DV 计划的EUD的OAR剂量要高于没有DV 计划的EUD的OAR剂量。与均匀剂量分布(带有DV 的EUD )相比,在目标内允许不均匀剂量(EUD Without DV )可以实现更好的正常组织备用。因此,可以将这种不均匀剂量故意倾倒在高风险的量上,以实现较高的局部控制。因此,可以得出结论,EUD优化计划提供了更少的OAR剂量以及选择性地增加总肿瘤体积剂量的额外优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号